Ezra

以斯拉

, the health-tech pioneer that has transformed early cancer detection in the US, has launched its AI-powered full-body MRI screening service in the UK – marking a major expansion beyond the US. The next-generation AI-powered screening solution is now available in London, with plans for a nationwide roll out throughout 2025..

，这家健康科技先锋已经改变了美国的早期癌症检测，现已在英国推出其人工智能驱动的全身核磁共振筛查服务——标志着其在美国以外的重大扩张。这款下一代人工智能筛查解决方案现已在伦敦推出，并计划于2025年在全国范围内推广。

As part of the UK launch, Ezra has partnered with

作为英国上市的一部分，Ezra 已与

Alliance Medical

联盟医疗

, one of Europe’s leading independent providers of diagnostic imaging services. Alliance Medical will offer Ezra’s full-body MRI scans at its Marylebone clinic, with additional locations to follow. The partnership ensures that Ezra’s AI-driven cancer screening benefits from established clinical expertise and a trusted diagnostic network, making advanced early detection more widely accessible..

，欧洲领先的独立诊断影像服务提供商之一。Alliance Medical 将在其 Marylebone 诊所提供 Ezra 的全身核磁共振扫描服务，并计划扩展到更多地点。该合作确保了 Ezra 的人工智能驱动的癌症筛查能够受益于成熟的临床专业知识和可靠的诊断网络，使先进的早期检测技术更为普及。

Ezra’s AI-powered platform enhances MRI-based cancer screening by significantly reducing scan times, improving clinical workflow efficiencies, and providing an innovative E-SCORE system to help prioritise findings. The service is designed to detect cancer and other serious health conditions early, scanning 13 organs using non-contrast MRI technology, including the brain, liver, kidneys, prostate, uterus, and spine, all in a single 60-minute session..

Ezra的AI驱动平台通过大幅减少扫描时间、提高临床工作流程效率，并提供创新的E-SCORE系统来帮助优先处理发现结果，从而增强了基于MRI的癌症筛查。该服务旨在早期检测癌症和其他严重健康问题，利用非对比MRI技术扫描13个器官，包括大脑、肝脏、肾脏、前列腺、子宫和脊柱，所有这些都在单次60分钟的会话中完成。

Cancer Research UK

英国癌症研究中心

reports a 24% increase in cancer diagnoses among people in their 40s and 50s since 1995. Despite advances in treatment, nearly half of all cancer cases in the UK are still diagnosed at late stages, limiting treatment options and outcomes. Ezra’s mission is to shift this dynamic by making AI-powered early screening more accessible to individuals who may benefit from proactive monitoring, including those with a family history of cancer or other risk factors..

自1995年以来，报告称40至50岁人群中癌症诊断增加了24%。尽管治疗方面取得了进展，但英国近一半的癌症病例仍处于晚期才被诊断，限制了治疗选择和效果。Ezra的使命是通过让可能受益于主动监测的个体（包括有癌症家族史或其他风险因素的人）更容易获得人工智能驱动的早期筛查，来改变这种现状。

“Having witnessed the impact of late-stage cancer diagnosis in my own family, I understand the critical importance of early detection,”

“由于我亲眼目睹了家里人晚期癌症诊断的影响，我理解早期检测的重要意义，”

says

说

Emi Gal, CEO and founder of Ezra

Emi Gal，Ezra的首席执行官兼创始人

. “Our mission is to make comprehensive cancer screening fast, accurate and affordable.”

“我们的使命是让全面的癌症筛查变得快速、准确且实惠。”

Ezra has already facilitated tens of thousands of scans across 25 US cities, with its AI-powered system enhancing radiology workflows and improving scan interpretation. Each scan is reviewed by specialist radiologists, and findings are categorised with Ezra’s proprietary E-SCORE, allowing clinicians to prioritise results that require urgent follow-up.

Ezra已在美国25个城市开展了数万次扫描，其人工智能系统优化了放射科工作流程并提升了扫描解读的准确性。每次扫描均由专业放射科医生审阅，并通过Ezra专有的E-SCORE系统对结果进行分类，帮助临床医生优先处理需要紧急跟进的病例。

The company’s technology ensures that full-body MRI remains a non-invasive, radiation-free, and safe alternative for regular screening..

该公司技术确保全身核磁共振成像依然是常规筛查的非侵入性、无辐射和安全的替代方案。

The integration of AI into cancer diagnostics has the potential to optimise radiology workflows, support clinical decision-making, and expand screening capabilities beyond traditional hospital settings. Ezra’s AI technology reduces scan times while maintaining diagnostic accuracy, providing an efficient solution to the growing demand for preventative healthcare services..

将人工智能整合到癌症诊断中有助于优化放射科工作流程、支持临床决策，并将筛查能力扩展到传统医院环境之外。Ezra的AI技术在保持诊断准确性的同时减少了扫描时间，为不断增长的预防性医疗服务需求提供了高效解决方案。

“We are delighted to introduce full-body MRI screening in partnership with Ezra. Its AI-driven approach represents the future of early cancer detection, and we are excited to integrate this technology into our imaging services to enhance diagnostic precision and accessibility,”

“我们很高兴与Ezra合作推出全身核磁共振筛查。其人工智能驱动的方法代表了早期癌症检测的未来，我们非常兴奋将这项技术整合到我们的影像服务中，以提高诊断的精确性和可及性。”

says

说

Peter Winchester, Managing Director of Alliance Medical UK

彼得·温彻斯特，英国联盟医疗公司总经理

.

。

“Early detection can dramatically improve cancer survival rates, yet 50% of cancers in the UK are diagnosed at late stages,”

“早期发现可以显著提高癌症的存活率，然而在英国，50%的癌症是在晚期被诊断出来的。”

says Dr Dan Brook, Ezra’s UK Medical Director.

埃兹拉英国医学总监丹·布鲁克博士说。

“Our technology provides a powerful new tool for early detection, particularly for individuals with family history or elevated risk factors.”

“我们的技术为早期检测提供了一个强有力的新工具，特别是对于有家族病史或风险因素升高的个体。”

Scans at the Ezra partner clinic in Marylebone can be booked via the Ezra website (

可以通过Ezra网站预订位于玛丽勒博恩的Ezra合作诊所的扫描检查 (

www.ezra.com

www.ezra.com

)

)

from Monday, 24th February 2025, with the company planning to introduce a faster 30-minute MRI scan later this year and expand nationwide in 2025.

从2025年2月24日星期一开始，该公司计划在今年晚些时候推出更快的30分钟核磁共振扫描，并于2025年在全国范围内扩展。

Services and pricing:

服务和定价：

Ezra Full Body: £2,395 (13-organ MRI scan)

Ezra 全身扫描：£2,395（13器官MRI扫描）

Ezra Full Body Plus: £2,695 (includes low-dose chest CT for lung cancer and heart disease screening

Ezra 全身检查 Plus：£2,695（包括用于肺癌和心脏病筛查的低剂量胸部 CT）

Clinicians and healthcare providers can refer patients or book scans directly at

临床医生和医疗保健提供者可以直接为患者预约或预订扫描

www.ezra.com

www.ezra.com

, with results accessible via the secure MyEzra portal. The partnership with Alliance Medical ensures patients benefit from established clinical expertise and cutting-edge AI technology, driving forward a new standard in cancer screening.

，结果可通过安全的MyEzra门户获取。与Alliance Medical的合作确保患者受益于成熟的临床专业知识和尖端的人工智能技术，推动癌症筛查的新标准。